Technology area: Communications
1 pending office actions • 1 art units • 1 examiners • 0 of 1 (0%) have an AI response strategy ready
X-Zell Biotech Pte. Ltd. operates within the Communications technology area. The company's patent prosecution profile currently shows 1 pending office action. This 1 pending office action represents a focused and singular engagement with the USPTO for the company's current filings.
The data indicates that all prosecution activity is restricted to 1 distinct examiner and 1 distinct art unit. The busiest examiner for this portfolio is KRASNIC, BERNARD, who is responsible for 1 pending office action. This concentration suggests that the technical subject matter of the pending application is specific to a particular sub-field within Communications.
With only 1 distinct examiner and 1 distinct art unit involved, the applicant faces a very specific examination environment. Practitioners can concentrate their efforts on the specific requirements of KRASNIC, BERNARD, as this individual is the sole examiner for the current pending workload. This streamlined environment allows for a targeted response to the 1 pending office action without the complexity of managing multiple examiners for X-Zell Biotech Pte. Ltd.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §103 only | 1 (100%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| KRASNIC, BERNARD | 1 | 77.9% | +57.1% |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18558041 | MACHINE LEARNING SYSTEMS AND METHODS FOR IDENTIFYING AND CLASSIFYING RARE CELLS | KRASNIC, BERNARD | — |
| Art Unit | Apps |
|---|---|
| 2671 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18558041 | MACHINE LEARNING SYSTEMS AND METHODS FOR IDENTIFYING AND CLASSIFYING RARE CELLS | KRASNIC, BERNARD | 2671 | §103 | Final Rejection | — | Pending | Oct 30, 2023 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free TrialX-Zell Biotech Pte. Ltd. has 1 pending office actions as of October 2026, spread across 1 art units and 1 examiners.
Bernard Krasnic has the most, with 1 of X-Zell Biotech Pte. Ltd.'s pending office actions.
Mostly Communications (USPTO Tech Center 2600), based on where its pending office actions are examined.
